UK markets close in 1 hour 38 minutes

Kane Biotech Inc. (KNE.V)

TSXV - TSXV Real-time price. Currency in CAD
Add to watchlist
0.1500+0.0050 (+3.45%)
As of 09:40AM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
2,744
156.733
1,608
1,342
1,694
Cost of revenue
1,433
44.704
1,039
814.715
1,084
Gross profit
1,311
112.029
568.441
526.859
609.912
Operating expenses
Research development
837.889
1,036
1,377
1,326
1,541
Selling general and administrative
3,777
2,534
4,075
3,425
2,659
Total operating expenses
4,614
3,570
5,452
4,751
4,200
Operating income or loss
-3,303
-3,458
-4,884
-4,224
-3,590
Interest expense
1,236
816.664
416.057
121.556
141.675
Total other income/expenses net
-27.018
237.168
327.773
461.653
2,771
Income before tax
-4,496
-4,022
-4,850
-3,846
-960.178
Income from continuing operations
-4,496
-4,022
-4,850
-3,846
-960.178
Net income
-4,322
-3,890
-4,605
-3,717
-960.178
Net income available to common shareholders
-4,322
-3,890
-4,605
-3,717
-960.178
Basic EPS
-0.04
-0.03
-0.04
-0.03
-0.01
Diluted EPS
-0.04
-0.03
-0.04
-0.03
-0.01
Basic average shares
112,600
120,702
112,600
108,614
82,304
Diluted average shares
112,600
120,702
112,600
108,614
82,304